Gilles Ivaldi

European Institute of Oncology

Papers

1

Total Citations

283

H-Index

1

About

Gilles Ivaldi is a pioneering radiation oncologist whose work has significantly advanced the treatment of early-stage breast cancer through intraoperative radiotherapy (IORT). His research focuses on refining conservative breast cancer management, particularly by integrating targeted radiation during surgery to minimize damage to healthy tissue. Ivaldi’s landmark 2001 study, “A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated,” has garnered over 280 citations, establishing a foundational protocol for IORT in breast-conserving therapy. This work demonstrated that delivering a single, high-dose fraction of radiation directly to the tumor bed immediately after lumpectomy could achieve local control comparable to conventional whole-breast irradiation, while reducing treatment duration and side effects. His contributions have helped shape modern breast cancer treatment paradigms, offering patients shorter, more precise therapeutic options. Ivaldi’s ongoing influence is evident in the widespread adoption of IORT techniques and his role in multicenter trials that validate these approaches, making him a key figure in the evolution of personalized, less invasive oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
283
Total Citations
283
Avg Citations/Paper
🏆 Most Cited Paper
A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated
283 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago